Literature DB >> 10406048

Respiratory function in children undergoing bone marrow transplantation.

H Leneveu1, F Brémont, H Rubie, M C Peyroulet, A Broué, A Suc, A Robert, G Dutau.   

Abstract

We conducted a prospective study of respiratory function in children undergoing bone marrow transplantation (BMT) for onco-hematological disorders. Each child was evaluated before and 100 days after BMT. The investigations included clinical examination, chest X-ray, and pulmonary function tests (PFT) to determine: slow vital capacity (VC), functional residual capacity (FRC), total lung capacity (TLC), forced expiratory volume in 1 s (FEV1), carbon monoxide diffusing capacity (DLCO), ratio of residual volume (RV) to TLC, and FEV1/VC. The values obtained before and after BMT were compared to predicted values, and the post-BMT values were compared to the pre-BMT values (Student's t-test). From 1986 to 1995, 77 children underwent BMT, of whom 39 were available for testing. The pre-BMT VC (P = 0.0234) and DLCO (P < 0.0001) were lower and FRC higher (P < 0.0001) than predicted values. After BMT, the VC (P = 0.004), TLC (P = 0.044), and FEV1 (P = 0.012) were lower, and the RV/TLC ratio was higher (P = 0.043), compared with pre-BMT data. The observed respiratory abnormalities were not clinically relevant. The only identifiable risk factor for a decrease in lung function was age at BMT. This study shows that some lung dysfunction may be present before BMT and be further altered by BMT. This stresses the need for longitudinal respiratory monitoring and follow up to detect such dysfunctions and to insure an optimal treatment program for these children.

Entities:  

Mesh:

Year:  1999        PMID: 10406048     DOI: 10.1002/(sici)1099-0496(199907)28:1<31::aid-ppul6>3.0.co;2-j

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

1.  High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient.

Authors:  Courtney M Rowan; Ashley Loomis; Jennifer McArthur; Lincoln S Smith; Shira J Gertz; Julie C Fitzgerald; Mara E Nitu; Elizabeth As Moser; Deyin D Hsing; Christine N Duncan; Kris M Mahadeo; Jerelyn Moffet; Mark W Hall; Emily L Pinos; Robert F Tamburro; Ira M Cheifetz
Journal:  Respir Care       Date:  2017-12-26       Impact factor: 2.258

2.  Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.

Authors:  R Majzner; C Sandoval; A J Dozor; Z Jin; C van de Ven; R Dalal; E Morris; L Harrison; K Wolownik; S Fabricatore; L A Baxter-Lowe; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2016-06-20       Impact factor: 5.483

3.  Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Jie Yang; Jianmin Pan; Dennis C Stokes; Matthew J Krasin; Ashok Srinivasan; Christine M Hartford; Ching-Hon Pui; Wing Leung
Journal:  Cancer       Date:  2010-04-15       Impact factor: 6.860

Review 4.  Pulmonary outcomes in survivors of childhood cancer: a systematic review.

Authors:  Tseng-Tien Huang; Melissa M Hudson; Dennis C Stokes; Matthew J Krasin; Sheri L Spunt; Kirsten K Ness
Journal:  Chest       Date:  2011-03-17       Impact factor: 9.410

Review 5.  Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.

Authors:  Courtney D Fitzhugh; Emmanuel J Volanakis; Ombeni Idassi; Josh A Duberman; Michael R DeBaun; Debra L Friedman
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.